Ankylosing Spondylitis
Ankylosing Spondylitis ( 15 Questions)
Which class of medications is considered the first-line treatment to reduce inflammation and relieve pain in this condition?
Disease-modifying antirheumatic drugs (DMARDs) are not typically considered first-line treatment for Ankylosing Spondylitis. While they are used in some cases, nonsteroidal anti-inflammatory drugs (NSAIDs) are the primary first-line treatment for reducing inflammation and relieving pain in this condition.
Nonsteroidal anti-inflammatory drugs (NSAIDs) are considered the first-line treatment for Ankylosing Spondylitis. They help reduce inflammation and alleviate pain in affected individuals. This class of medication is often effective in managing the symptoms of the disease.
Biologic agents are typically reserved for individuals with Ankylosing Spondylitis who do not respond adequately to NSAIDs or have severe, progressive disease. They are not the first-line treatment option.
Corticosteroids may be used in some cases to manage acute symptoms or as a short-term intervention, but they are not considered the first-line treatment for Ankylosing Spondylitis due to their potential side effects and limited long-term efficacy.
Choice A rationale:
Disease-modifying antirheumatic drugs (DMARDs) are not typically considered first-line treatment for Ankylosing Spondylitis.
While they are used in some cases, nonsteroidal anti-inflammatory drugs (NSAIDs) are the primary first-line treatment for reducing inflammation and relieving pain in this condition.
Choice B rationale:
Nonsteroidal anti-inflammatory drugs (NSAIDs) are considered the first-line treatment for Ankylosing Spondylitis.
They help reduce inflammation and alleviate pain in affected individuals.
This class of medication is often effective in managing the symptoms of the disease.
Choice C rationale:
Biologic agents are typically reserved for individuals with Ankylosing Spondylitis who do not respond adequately to NSAIDs or have severe, progressive disease.
They are not the first-line treatment option.
Choice D rationale:
Corticosteroids may be used in some cases to manage acute symptoms or as a short-term intervention, but they are not considered the first-line treatment for Ankylosing Spondylitis due to their potential side effects and limited long-term efficacy.